Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A multi center phase Ib trial evaluating the safety and efficacy of lacutamab in patients with relapse peripheral T cell lymphoma that express KIR3DL2
NCT Number:
NCT05321147
Phase:
I
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Non-Hodgkin's Lymphoma
Study Objectives:
This is a multi-center phase 1b clinical trial. All patients will receive lacutamab until progression or unacceptable toxicity. Approximately 20 patients will be initially included in the study. Depending on safety profile and preliminary level of clinical activity, 20 more patients could be added.
Study Documents
(MUSC NetID required for document access)